Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Breast Cancer Active Surveillance Alternative Option, Can Aspirin Make the Difference?

NCT03491410 is registered in ClinicalTrials.gov with Centro Hospitalar Lisboa Ocidental as lead sponsor.

NCT NCT03491410
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03491410 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Breast Cancer Active Surveillance Alternative Option, Can Aspirin Make the Difference?
Lead sponsor
Centro Hospitalar Lisboa Ocidental
Phase
Phase 2/3
Overall status
Unknown status
Start date
June 1, 2018
Completion date
May 31, 2023
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer